Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy
Hanqiu Zheng(Shanxi Medical University), Yibin Kang(Rutgers, The State University of New Jersey), Guangwen Ren(Jackson Laboratory), Jodi Moriguchi(Amgen (United States)), Tupitsyn Nn, Brendan Lee(Baylor College of Medicine), Lanjing Zhang(Rutgers, The State University of New Jersey), Klaus Pantel(Universität Hamburg), H. Toni Jun(Mabvax Therapeutics (United States)), Yong Wei(The Ohio State University), Min Yuan(Tongji University), Jin Chen(Princeton University), Yangjin Bae(Baylor College of Medicine), Mark Esposito(Princeton University), Minhong Shen(Fudan University Shanghai Cancer Center), Wenyang Li(Princeton University), Jan Sun(Amgen (United States)), Chadwick King(Amgen (Canada)), Angela Coxon(Amgen (United States)), Rebecca Tang(Princeton University), Sabine Kasimir‐Bauer(University of Duisburg-Essen)
Cited by 159
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k
Pre-metastatic niches: organ-specific homes for metastases
|Nature reviews. Cancer|2017|1.9k